Strate Labs
stratelabs.com ↗Company Overview
Strate Labs is a long-established peptide and research chemical vendor operating out of Spring, Texas (registered in Delaware). The company claims over a decade of operation, making it one of the longer-tenured vendors in the grey-market peptide space. They operate multiple domains — stratelabs.com (primary), stratelabs.is (backup), and previously stratelabs.ca — selling peptides, SARMs (capsule form), and research chemicals. They also sell specialty products like “Rhino Rub,” a topical muscle balm infused with BPC-157 and TB-500.
Strate Labs has built a customer base primarily through TikTok influencer marketing and affiliate codes. Their product catalog spans approximately 51 peptide products alongside SARMs and ancillaries.
The ITC Cease and Desist Order — Context Matters
The headline finding: Strate Labs received a Cease and Desist Order from the US International Trade Commission as part of Investigation No. 337-TA-1386 (Eli Lilly v. multiple respondents). This is a serious federal enforcement action.
The critical context: This CDO is specifically about tirzepatide products. Eli Lilly purchased tirzepatide from Strate Labs, and the products were found to be manufactured by Semathin Ltd of Ontario, Canada — meaning Strate Labs was importing foreign-manufactured tirzepatide and selling it from their Texas location. Strate Labs was found in default on May 15, 2024 for failure to respond to the ITC complaint.
What the CDO covers:
- Products containing or purporting to contain tirzepatide
- Found liable for false designation of origin (the products were imported but sold as if domestic)
- Violation penalties: up to $100,000/day or 2x domestic value of goods
What the CDO does NOT cover:
- Strate Labs’ non-tirzepatide products (BPC-157, TB-500, SARMs, GHK-Cu, etc.)
- Their broader business operations outside the tirzepatide import issue
PeptideExaminer note: The ITC CDO is the most serious regulatory action in our vendor database. However, it’s important to understand its scope. Many grey-market vendors were caught in the same Lilly enforcement sweep (Arctic Peptides, Swiss Chems, Paradigm Peptides, GenX Peptides, and others were investigated). The CDO reflects specifically on Strate Labs’ decision to sell imported tirzepatide — a product that was always the highest-risk item in any vendor’s catalog. It does not necessarily indicate quality problems with their other products. That said, failure to respond to a federal ITC complaint is itself a red flag about business governance.
Quality & Testing
Score: 60/100
- Claims third-party testing on all products
- Website FAQ includes detailed discussion of peptide polymorphism and quality considerations
- COAs referenced but accessibility and lab identification could be more transparent
- Product catalog is extensive (~51 peptides) suggesting established supply chain
Not in Finnrick database: No independent verification through Finnrick Analytics.
Limitation: Claims of third-party testing are common across the industry. Without Finnrick inclusion or clearly identified independent lab partners, these claims carry less weight.
Customer Experience
Score: 55/100
Strate Labs has been operating for over a decade, which is significant longevity in a market where many vendors appear and disappear within a year or two. Community feedback suggests:
- Product quality: Generally not a major complaint area — the primary issues reported are around customer service and communication
- Customer service: This is the main pain point. Response times and communication have been flagged as inconsistent
- Shipping: Generally functional but not always fast
- Knoji: 64 ratings, composite score 3.9/5 (individual star average ~2.6/5 — the discrepancy reflects Knoji’s scoring methodology which includes feature evaluation alongside user ratings)
- TikTok presence: Significant — multiple influencers promote Strate Labs with affiliate codes (e.g., “AP,” “degen”), which is a double-edged sword: it drives awareness but means many “reviews” are financially incentivized
No Trustpilot presence found: Strate Labs does not appear to have a Trustpilot profile. (Note: “Strats Labs” on Trustpilot is an unrelated trading education company — not the peptide vendor.)
Transparency
Score: 50/100
- Physical shipping from Spring, Texas
- Business registered in Delaware (per ZoomInfo)
- Multiple domains (could be interpreted as resilience planning or enforcement evasion)
- “Research purposes only” disclaimers on products
- FAQ includes substantive quality discussion (polymorphism, stability)
- Ownership/founder not publicly identified
Pricing
Score: 70/100
Strate Labs positions itself at the budget-competitive end of the market, advertising “Lowest Prices in The Industry” with free shipping on orders over $250. Pricing appears competitive relative to mid-range vendors. Discount codes are widely available through influencer partnerships.
Compliance
Score: 20/100
The ITC CDO is the dominant factor here. While it’s tirzepatide-specific, it represents:
- A finding of default in a federal proceeding (failure to respond)
- Confirmed importation of foreign-manufactured products (Semathin Ltd, Ontario, Canada)
- False designation of origin liability
- Active cease and desist order with substantial penalty exposure
Additionally:
- Sells SARMs in capsule form — positioned closer to consumer supplement than research chemical
- TikTok marketing with affiliate codes — influencers openly discuss human use and personal results, contradicting “research only” positioning
- Still appears to sell tirzepatide and retatrutide products as of February 2026 (if so, this would be in direct defiance of the CDO and General Exclusion Order)
No FDA warning letters on record. No BBB complaints identified.
Red Flags
- ITC Cease and Desist Order (tirzepatide-specific) — most serious regulatory action in our database
- Found in default for not responding to federal complaint — suggests lack of legal governance
- TikTok influencer marketing with affiliate codes — incentivized reviews undermine trustworthiness of positive feedback
- Multiple domains — .com, .is, .ca — could indicate domain resilience planning
- Still listing GLP-1 products — if selling tirzepatide post-CDO, this represents ongoing federal violation
Positives
- Longevity: Over a decade of operation — meaningful in a market where vendors frequently disappear
- Broad catalog: 51+ peptides suggests established supply chain relationships
- Competitive pricing: Budget-friendly positioning
- Product quality not primary complaint: Community feedback focuses on customer service issues rather than product quality concerns
- Quality discussion: FAQ demonstrates familiarity with analytical concepts (polymorphism, stability)
The PeptideExaminer Verdict
Strate Labs presents a genuinely mixed picture. They’ve operated for over a decade and built a real customer base, with complaints centering on customer service rather than product quality — that’s actually a better signal than many newer vendors. However, the ITC Cease and Desist Order for tirzepatide importation is a federal enforcement action that cannot be ignored, even though it’s product-specific. The failure to respond to the ITC complaint, combined with heavy influencer marketing and continued GLP-1 sales, creates a compliance profile that drags down an otherwise middle-of-the-pack vendor.
For non-GLP-1 products (BPC-157, TB-500, SARMs): The vendor’s track record is more defensible, though the lack of Finnrick verification and non-transparent COA sourcing remain limitations.
For GLP-1 products (tirzepatide, semaglutide, retatrutide): Avoid. Active federal enforcement makes these purchases high-risk.
Grade: C-
| Category | Score | Weight | Weighted |
|---|---|---|---|
| Transparency | 50 | 20% | 10.0 |
| Testing | 60 | 25% | 15.0 |
| Pricing | 70 | 15% | 10.5 |
| Reputation | 55 | 20% | 11.0 |
| Compliance | 20 | 20% | 4.0 |
| Total | 50.5 → C- |
Correction note (2/20/26): Removed incorrectly attributed Trustpilot data (belonged to unrelated ‘Strats Labs’ trading education company). Added longevity context and nuanced ITC analysis. Adjusted grade from D to C-.
Sources: ITC Investigation 337-TA-1386, Federal Register, Knoji, stratelabs.com